N-(3-Bromophenyl)-3-(trifluoromethyl)benzamide, 97%, 1g

4-Ethoxy-6-(3-methyl-piperazin-1-yl)-2-methylsulfanyl-pyrimidine hydrochloride, 95.0%, 250mg

3-Chlorothiophene-2-carboxylic acid, 98.0%, 1g

Maprotiline Hydrochloride, >98.0%(HPLC)(T), 200mg

N-(4-methylphenyl)-2,3-dihydrothiophen-3-amine 1,1-dioxide, 95.0%, 2.5g

Mercury(II) chloride, min. 99.5%, pa, ACS, 100 g, glass packaging

3-Chlorophenacyl bromide, 90.0%, 5g

2-(4-(Benzyloxy)-2-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100mg

Ethyl 4-amino-2-thioxo-1,2-dihydro-pyrimidine-5-carboxylate, 97.0%, 10g

N-(17-Hydroxy-3,6,9,12,15-pentaoxaheptadecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 50mg

2-[2-(tert-Butoxy)-2-oxoethoxy]acetic acid, 95%, 5g

3-Chloro-2-fluoro-6-nitrophenol, 98%, 500mg

1-(6-Bromopyridin-3-yl)ethan-1-ol, 97%, 25g